Drug AlertsNovember 29, 2022 | FDA Approvals/EUAs/New Indications Family Medicine/General Practice FDA Authorizes IL-1 Drug for Hospitalized COVID Patients Anakinra (Kineret, Sobi) currently approved for rheumatoid arthritis and some rare disorders, was granted an emergency use authorization for a subgroup of COVID-hospitalized patients who are at risk of severe respiratory failure. Read full article Allergy & Immunology FDA Panel Backs Novel Combination Inhaler for Asthma in Adults Only Although the panel voted 16:1 for the new budesonide + albuterol inhaler in adults, they said the data does not support use in children and they were split on use in adolescents over the age of 12. Read full article
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH